文献速递前列腺增生与排尿功能障碍

经皮胫神经刺激治疗膀胱过度活动症:临床疗效、尿动力学及持久性评估

Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation.
PubMed 文献 · Urology · 2017-07-04

这项前瞻性研究纳入2007至2015年西班牙马拉加Virgen de la Victoria大学医院的200例女性膀胱过度活动症患者,抗毒蕈碱药物治疗失败后接受经皮胫神经刺激(PTNS)。94%的患者在临床和尿动力学参数上获得阳性反应,获益持续24个月;日间排尿频率和膀胱充盈初始感觉是PTNS成功的显著独立预测因素。

要点

  • 抗毒蕈碱药物治疗失败的女性OAB患者中,94%对PTNS治疗有阳性反应。
  • PTNS获益持续24个月。
  • 日间排尿频率和膀胱充盈初始感觉是PTNS成功的显著独立预测因素。

核心结论

  • 当前数据证实PTNS具有高有效性,可改善OAB症状并持续24个月。
  • 日间排尿频率和膀胱充盈初始感觉是PTNS成功的显著独立预测因素。

研究设计与样本

  • 前瞻性研究,纳入2007至2015年西班牙马拉加Virgen de la Victoria大学医院的200例确诊OAB女性患者。
  • OAB患者在抗毒蕈碱药物治疗失败后接受PTNS治疗。
  • 治疗前后进行临床和尿动力学检查以评估OAB症状。
  • 治疗成功定义为临床参数下降>50%且至少2项尿动力学参数改善>50%。
  • 采用Kolmogorov-Smirnov检验及Student t检验或Wilcoxon检验,并进行线性相关分析和多因素线性回归分析以确定与PTNS成功相关的因素。

主要发现

  • 94%的患者在临床和尿动力学参数方面对PTNS有阳性反应。
  • PTNS获益持续24个月。
  • 日间排尿频率与PTNS成功独立相关(r=-0.165;P=.024;95%CI,-0.248至-0.018)。
  • 膀胱充盈初始感觉与PTNS成功独立相关(r=0.208;P=.030;95%CI,0.001至0.028)。

关键数值与推荐

  • 治疗成功定义为临床参数下降>50%且至少2项尿动力学参数改善>50%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate percutaneous tibial nerve stimulation (PTNS) effectiveness, durability, and impact on the pathophysiology of overactive bladder syndrome (OAB) in patients who have been previously treated with antimuscarinics without success. MATERIALS AND METHODS: A prospective study that included 200 women diagnosed with OAB between 2007 and 2015 at Virgen de la Victoria University Hospital (Málaga, Spain) was conducted. OAB patients were treated with PTNS therapy after antimuscarinic treatment failed. To evaluate OAB symptoms, clinical and urodynamic studies were performed before and after PTNS treatment. Treatment's success was defined as a reduction of clinical parameters by >50% and an improvement of at least 2 urodynamic parameters by >50%. The Kolmogorov-Smirnov test and Student's t test or Wilcoxon test were used based on the data. A linear correlation analysis and a multivariate linear regression analysis were performed to determine factors associated with the success of PTNS therapy. RESULTS: Of the patients, 94% experienced a positive response to PTNS considering clinical and urodynamic parameters. PTNS benefits were extended by 24 months. We identified daytime urinary frequency (r = -0.165; P = .024; 95% confidence interval, -0.248 to -0.018) and first sensation of bladder filling (r = 0.208; P = .030; 95% confidence interval, 0.001-0.028) as significant independent predictor factors for PTNS success. CONCLUSION: The current data confirmed a high effectiveness of PTNS improving OAB symptoms through 24 months. Furthermore, daytime urinary frequency and first sensation of bladder filling act as a significant independent predictor factors for PTNS success.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Del Río-Gonzalez S, Aragon IM, Castillo E, et al. Percutaneous Tibial Nerve Stimulation Therapy for Overactive Bladder Syndrome: Clinical Effectiveness, Urodynamic, and Durability Evaluation. Urology. 2017. PMID: 28687483. doi:10.1016/j.urology.2017.04.059

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。